Cargando…
Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study
OBJECTIVE: To investigate the role of acetylsalicylic acid (ASA) in reducing the incidence of cardiovascular (CV) events in an Italian multicentre rheumatoid arthritis (RA) inception cohort. METHODS: The clinical charts of RA patients consecutively admitted to 4 Italian centres for their 1(st) visit...
Autores principales: | Iacono, Daniela, Fasano, Serena, Pantano, Ilenia, D'Abrosca, Virginia, Ruscitti, Piero, Margiotta, Domenico Paolo Emanuele, Navarini, Luca, Maruotti, Nicola, Grembiale, Rosa Daniela, Cantatore, Francesco Paolo, Afeltra, Antonella, Giacomelli, Roberto, Valentini, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525948/ https://www.ncbi.nlm.nih.gov/pubmed/31192004 http://dx.doi.org/10.1155/2019/2748035 |
Ejemplares similares
-
Mortality in Italian patients with rheumatoid arthritis: evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center
por: Iacono, Daniela, et al.
Publicado: (2017) -
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
por: Iacono, Daniela, et al.
Publicado: (2018) -
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
por: Ruscitti, Piero, et al.
Publicado: (2019) -
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort
por: Di Benedetto, Paola, et al.
Publicado: (2020) -
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial
por: Ruscitti, Piero, et al.
Publicado: (2019)